US prescriptions for Novo's (NOVOB DC) wegovy pill were 18,410 for week ended Jan 16, according IQVIA data

The recent figure of 18,410 weekly prescriptions for Novo Nordisk's Wegovy pill indicates solid demand trends that could bolster revenue projections for the company.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

US PRE-MARKET MOVERS: NVDA, INTC, CSX, ISRG, SPOT, SLB, AMZN, DIS, CI, COF

Brazil President Lula tells Chinese President Xi that Brazil will exempt short-term visas to Chinese

US prescriptions for Novo's (NOVOB DC) wegovy pill were 18,410 for week ended Jan 16, according IQVIA data

France's Finance Minister says everything suggests that 2025 GDP was closer to 0.9% than the 0.7% they had expected

SLB (SLB) Q4 2025 (USD): Adj. EPS 0.78 (exp. 0.74), Revenue 9.75bln (exp. 9.55bln)

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This data is essential as it reflects not only consumer interest but also the medication's market penetration, which may influence investor sentiment towards Novo and provide insights into the broader healthcare sector's performance.

Related headlines

The whole workspace, free to try.

Try it free